世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Womens Health Market Size, Share & Trends Analysis Report By Application (Postmenopausal Osteoporosis, Infertility, Endometriosis & Uterine Fibroids), By Drug Class (Hormonal Therapies, Bone Health Agents), By Age, By Region, And Segment Forecasts, 2026 - 2033
Women’s Health Market Summary The global women’s health market size was estimated at USD 53.48 billion in 2025 and is projected to reach USD 75.42 billion by 2033, growing at a CAGR of 5.1% fro... もっと見る
英語原文をAIを使って翻訳しています。
SummaryWomen’s Health Market SummaryThe global women’s health market size was estimated at USD 53.48 billion in 2025 and is projected to reach USD 75.42 billion by 2033, growing at a CAGR of 5.1% from 2026 to 2033. Market growth can be attributed to the increase in the geriatric population of women and the introduction of new advanced therapeutic applications for women’s health. Furthermore, favorable policies initiated by governments to improve women’s health and raise awareness are likely to drive market growth during the forecast period. The market for women s health is increasingly defined by a lifecycle approach that extends beyond reproductive care to include maternal health, fertility, menopause management, and gender specific diagnostics. Governments and multilateral agencies are reinforcing women’s health as a health system priority, influencing regulation, reimbursement, and funding alignment across regions. World Health Organization continues to emphasize sexual and reproductive health and rights as foundational to health system resilience and equity, shaping policy agendas globally. Regulatory scrutiny has intensified around safety, evidence generation, and inclusion of women across life stages in clinical research, particularly in areas such as hormone therapies and menopause care. This has direct implications for application development strategies, labeling pathways, and post market surveillance requirements. In parallel, healthcare companies are positioning women’s health as a strategic growth and responsibility area within annual reports and investor communications, highlighting increased focus on diagnostics, fertility technologies, and chronic condition management. Overall, the market is shaped by rising policy engagement, evolving regulatory expectations, and strategic corporate investment, with opportunities centered on evidence backed therapies, diagnostics, and scalable care models aligned with public health priorities. Global Women’s Health Market Report Segmentation This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global women’s health market report based on application, drug class, age, and region: ? Application Outlook (Revenue, USD Million, 2021 - 2033) ? Hormonal Infertility ? Contraceptives ? Postmenopausal Osteoporosis ? Endometriosis & Uterine Fibroids ? Menopause ? Polycystic Ovary Syndrome (PCOS) ? Drug Class Outlook (Revenue, USD Million, 2021 - 2033) ? Hormonal Therapies ? Bone Health Agents ? Fertility Agents ? GnRH Modulators ? Pain and Symptom Management ? Metabolic Agents ? Others ? Age Outlook (Revenue, USD Million, 2021 - 2033) ? 50 years and above o Postmenopausal Osteoporosis o Endometriosis & Uterine Fibroids o Menopause o Others ? Others ? Regional Outlook (Revenue, USD Million, 2021 - 2033) ? North America o U.S. o Canada o Mexico ? Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway ? Asia Pacific o Japan o China o India o Australia o South Korea ? Thailand o Latin America o Brazil o Argentina ? Middle East & Africa o South Africa o Saudi Arabia o UAE o Kuwait Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Application 1.2.2. Drug Class 1.2.3. Age 1.3. Estimates and Forecast Timeline 1.4. Research Methodology 1.5. Information Procurement 1.5.1. Purchased Database 1.5.2. GVR’s Internal Database 1.5.3. Secondary Sources 1.5.4. Primary Research 1.6. Information Analysis 1.6.1. Data Analysis Models 1.7. Market Formulation & Data Visualization 1.8. Model Details 1.8.1. Commodity Flow Analysis 1.9. List of Secondary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Segment Snapshot 2.3. Competitive Landscape Snapshot Chapter 3. Women’s Health Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.2. Market Restraint Analysis 3.3. Business Environment Analysis 3.3.1. Industry Analysis - Porter’s Five Forces Analysis 3.3.1.1. Supplier Power 3.3.1.2. Buyer Power 3.3.1.3. Substitution Threat 3.3.1.4. Threat of New Entrants 3.3.1.5. Competitive Rivalry 3.3.2. PESTLE Analysis 3.3.3. Pipeline Analysis Chapter 4. Women’s Health Market: Application Business Analysis 4.1. Application Market Share, 2025 & 2033 4.2. Application Segment Dashboard 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million) 4.4. Hormonal Infertility 4.4.1. Hormonal Infertility Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5. Contraceptives 4.5.1. Contraceptives Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.6. Postmenopausal Osteoporosis 4.6.1. Postmenopausal Osteoporosis Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.7. Endometriosis & Uterine Fibroids 4.7.1. Endometriosis & Uterine Fibroids Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.8. Menopause 4.8.1. Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.9. Polycystic Ovary Syndrome (PCOS) 4.9.1. Polycystic Ovary Syndrome (PCOS) Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 5. Women’s Health Market: Drug Class Business Analysis 5.1. Drug Class Market Share, 2025 & 2033 5.2. Drug Class Segment Dashboard 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million) 5.4. Hormonal Therapies 5.4.1. Hormonal Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.5. Bone Health Agents 5.5.1. Bone Health Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.6. Fertility Agents 5.6.1. Fertility Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.7. GnRH Modulators 5.7.1. GnRH Modulators Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.8. Pain and Symptom Management 5.8.1. Pain and Symptom Management Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.9. Metabolic Agents 5.9.1. Metabolic Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.10. Others 5.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 6. Women’s Health Market: Age Business Analysis 6.1. Age Market Share, 2025 & 2033 6.2. Age Segment Dashboard 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million) 6.4. 50 years and above 6.4.1. 50 years and above Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.2. Postmenopausal Osteoporosis 6.4.2.1. Postmenopausal Osteoporosis Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.3. Endometriosis & Uterine Fibroids 6.4.3.1. Endometriosis & Uterine Fibroids Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.4. Menopause 6.4.4.1. Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.5. Others 6.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5. Others 6.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 7. Women’s Health Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2025 & 2033 7.2. Regional Market Dashboard 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033: 7.4. North America 7.4.1. North America Women’s Health Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million) 7.4.2. U.S. 7.4.2.1. Key Country Dynamics 7.4.2.2. Type Disease Prevalence 7.4.2.3. Regulatory Framework 7.4.2.4. Reimbursement Framework 7.4.2.5. U.S. Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.4.3. Canada 7.4.3.1. Key Country Dynamics 7.4.3.2. Type Disease Prevalence 7.4.3.3. Regulatory Framework 7.4.3.4. Reimbursement Framework 7.4.3.5. Canada Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.4.4. Mexico 7.4.4.1. Key Country Dynamics 7.4.4.2. Type Disease Prevalence 7.4.4.3. Regulatory Framework 7.4.4.4. Reimbursement Framework 7.4.4.5. Mexico Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5. Europe 7.5.1. Europe Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.2. UK 7.5.2.1. Key Country Dynamics 7.5.2.2. Type Disease Prevalence 7.5.2.3. Regulatory Framework 7.5.2.4. Reimbursement Framework 7.5.2.5. Uk Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.3. Germany 7.5.3.1. Key Country Dynamics 7.5.3.2. Type Disease Prevalence 7.5.3.3. Regulatory Framework 7.5.3.4. Reimbursement Framework 7.5.3.5. Germany Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.4. France 7.5.4.1. Key Country Dynamics 7.5.4.2. Type Disease Prevalence 7.5.4.3. Regulatory Framework 7.5.4.4. Reimbursement Framework 7.5.4.5. France Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.5. Italy 7.5.5.1. Key Country Dynamics 7.5.5.2. Type Disease Prevalence 7.5.5.3. Regulatory Framework 7.5.5.4. Reimbursement Framework 7.5.5.5. Italy Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.6. Spain 7.5.6.1. Key Country Dynamics 7.5.6.2. Type Disease Prevalence 7.5.6.3. Regulatory Framework 7.5.6.4. Reimbursement Framework 7.5.6.5. Spain Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.7. Denmark 7.5.7.1. Key Country Dynamics 7.5.7.2. Type Disease Prevalence 7.5.7.3. Regulatory Framework 7.5.7.4. Reimbursement Framework 7.5.7.5. Denmark Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.8. Sweden 7.5.8.1. Key Country Dynamics 7.5.8.2. Type Disease Prevalence 7.5.8.3. Regulatory Framework 7.5.8.4. Reimbursement Framework 7.5.8.5. Sweden Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.5.9. Norway 7.5.9.1. Key Country Dynamics 7.5.9.2. Type Disease Prevalence 7.5.9.3. Regulatory Framework 7.5.9.4. Reimbursement Framework 7.5.9.5. Norway Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6. Asia Pacific 7.6.1. Asia Pacific Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.2. Japan 7.6.2.1. Key Country Dynamics 7.6.2.2. Type Disease Prevalence 7.6.2.3. Regulatory Framework 7.6.2.4. Reimbursement Framework 7.6.2.5. Japan Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.3. China 7.6.3.1. Key Country Dynamics 7.6.3.2. Type Disease Prevalence 7.6.3.3. Regulatory Framework 7.6.3.4. Reimbursement Framework 7.6.3.5. China Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.4. India 7.6.4.1. Key Country Dynamics 7.6.4.2. Type Disease Prevalence 7.6.4.3. Regulatory Framework 7.6.4.4. Reimbursement Framework 7.6.4.5. India Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.5. Australia 7.6.5.1. Key Country Dynamics 7.6.5.2. Type Disease Prevalence 7.6.5.3. Regulatory Framework 7.6.5.4. Reimbursement Framework 7.6.5.5. Australia Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.6. South Korea 7.6.6.1. Key Country Dynamics 7.6.6.2. Type Disease Prevalence 7.6.6.3. Regulatory Framework 7.6.6.4. Reimbursement Framework 7.6.6.5. South Korea Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.6.7. Thailand 7.6.7.1. Key Country Dynamics 7.6.7.2. Type Disease Prevalence 7.6.7.3. Regulatory Framework 7.6.7.4. Reimbursement Framework 7.6.7.5. Thailand Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.7. Latin America 7.7.1. Latin America Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.7.2. Brazil 7.7.2.1. Key Country Dynamics 7.7.2.2. Type Disease Prevalence 7.7.2.3. Regulatory Framework 7.7.2.4. Reimbursement Framework 7.7.2.5. Brazil Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.7.3. Argentina 7.7.3.1. Key Country Dynamics 7.7.3.2. Type Disease Prevalence 7.7.3.3. Regulatory Framework 7.7.3.4. Reimbursement Framework 7.7.3.5. Argentina Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8. Middle East and Africa 7.8.1. Middle East and Africa Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.2. South Africa 7.8.2.1. Key Country Dynamics 7.8.2.2. Type Disease Prevalence 7.8.2.3. Regulatory Framework 7.8.2.4. Reimbursement Framework 7.8.2.5. South Africa Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.3. Saudi Arabia 7.8.3.1. Key Country Dynamics 7.8.3.2. Type Disease Prevalence 7.8.3.3. Regulatory Framework 7.8.3.4. Reimbursement Framework 7.8.3.5. Saudi Arabia Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.4. UAE 7.8.4.1. Key Country Dynamics 7.8.4.2. Type Disease Prevalence 7.8.4.3. Regulatory Framework 7.8.4.4. Reimbursement Framework 7.8.4.5. UAE Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) 7.8.5. Kuwait 7.8.5.1. Key Country Dynamics 7.8.5.2. Type Disease Prevalence 7.8.5.3. Regulatory Framework 7.8.5.4. Reimbursement Framework 7.8.5.5. Kuwait Women’s Health Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 8. Competitive Landscape 8.1. Participant Overview 8.2. Company Market Position Analysis 8.3. Company Categorization 8.4. Strategy Mapping 8.5. Company Profiles/Listing 8.5.1. AbbVie, Inc. 8.5.1.1. Overview 8.5.1.2. Financial Performance 8.5.1.3. Application Benchmarking 8.5.1.4. Strategic Initiatives 8.5.2. Bayer AG 8.5.2.1. Overview 8.5.2.2. Financial Performance 8.5.2.3. Application Benchmarking 8.5.2.4. Strategic Initiatives 8.5.3. Organon & Co. 8.5.3.1. Overview 8.5.3.2. Financial Performance 8.5.3.3. Application Benchmarking 8.5.3.4. Strategic Initiatives 8.5.4. Pfizer, Inc. 8.5.4.1. Overview 8.5.4.2. Financial Performance 8.5.4.3. Application Benchmarking 8.5.4.4. Strategic Initiatives 8.5.5. Agile Therapeutics 8.5.5.1. Overview 8.5.5.2. Financial Performance 8.5.5.3. Application Benchmarking 8.5.5.4. Strategic Initiatives 8.5.6. Amgen, Inc. 8.5.6.1. Overview 8.5.6.2. Financial Performance 8.5.6.3. Application Benchmarking 8.5.6.4. Strategic Initiatives 8.5.7. Apothecus Pharmaceutical Corp. 8.5.7.1. Overview 8.5.7.2. Financial Performance 8.5.7.3. Application Benchmarking 8.5.7.4. Strategic Initiatives 8.5.8. Blairex Laboratories, Inc. 8.5.8.1. Overview 8.5.8.2. Financial Performance 8.5.8.3. Application Benchmarking 8.5.8.4. Strategic Initiatives 8.5.9. Ferring 8.5.9.1. Overview 8.5.9.2. Financial Performance 8.5.9.3. Application Benchmarking 8.5.9.4. Strategic Initiatives 8.5.10. Theramex 8.5.10.1. Overview 8.5.10.2. Financial Performance 8.5.10.3. Application Benchmarking 8.5.10.4. Strategic Initiatives List of Tables/GraphsList of TablesTable 1 List of secondary sources Table 2 List of abbreviations Table 3 Global Women's Health Market, by Region, 2021 - 2033 (USD Million) Table 4 Global Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 5 Global Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 6 Global Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 7 North America Women's Health Market, by Country, 2021 - 2033 (USD Million) Table 8 North America Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 9 North America Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 10 North America Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 11 U.S. Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 12 U.S. Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 13 U.S. Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 14 Canada Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 15 Canada Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 16 Canada Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 17 Mexico Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 18 Mexico Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 19 Mexico Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 20 Europe Women's Health Market, by Country, 2021 - 2033 (USD Million) Table 21 Europe Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 22 Europe Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 23 Europe Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 24 UK Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 25 UK Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 26 UK Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 27 Germany Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 28 Germany Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 29 Germany Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 30 France Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 31 France Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 32 France Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 33 Italy Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 34 Italy Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 35 Italy Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 36 Spain Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 37 Spain Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 38 Spain Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 39 Denmark Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 40 Denmark Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 41 Denmark Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 42 Norway Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 43 Norway Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 44 Norway Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 45 Sweden Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 46 Sweden Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 47 Sweden Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 48 Asia Pacific Women's Health Market, by Country, 2021 - 2033 (USD Million) Table 49 Asia Pacific Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 50 Asia Pacific Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 51 Asia Pacific Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 52 Japan Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 53 Japan Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 54 Japan Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 55 China Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 56 China Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 57 China Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 58 India Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 59 India Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 60 India Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 61 South Korea Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 62 South Korea Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 63 South Korea Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 64 Australia Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 65 Australia Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 66 Australia Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 67 Thailand Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 68 Thailand Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 69 Thailand Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 70 Latin America Women's Health Market, by Country, 2021 - 2033 (USD Million) Table 71 Latin America Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 72 Latin America Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 73 Latin America Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 74 Brazil Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 75 Brazil Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 76 Brazil Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 77 Argentina Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 78 Argentina Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 79 Argentina Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 80 Middle East & Africa Women's Health Market, by Country, 2021 - 2033 (USD Million) Table 81 Middle East & Africa Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 82 Middle East & Africa Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 83 Middle East & Africa Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 84 South Africa Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 85 South Africa Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 86 South Africa Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 87 Saudi Arabia Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 88 Saudi Arabia Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 89 Saudi Arabia Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 90 UAE Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 91 UAE Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 92 UAE Women's Health Market, by Age, 2021 - 2033 (USD Million) Table 93 Kuwait Women's Health Market, by Application, 2021 - 2033 (USD Million) Table 94 Kuwait Women's Health Market, by Drug Class, 2021 - 2033 (USD Million) Table 95 Kuwait Women's Health Market, by Age, 2021 - 2033 (USD Million)List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Primary research pattern Fig. 4 Primary interviews in North America Fig. 5 Primary interviews in Europe Fig. 6 Primary interviews in APAC Fig. 7 Primary interviews in Latin America Fig. 8 Primary interviews in MEA Fig. 9 Market research approaches Fig. 10 Value-chain-based sizing & forecasting Fig. 11 QFD modeling for market share assessment Fig. 12 Market formulation & validation Fig. 13 Women's Health Fig. 14 Parent market outlook Fig. 15 Related/ancillary market outlook Fig. 16 Penetration and growth prospect mapping Fig. 17 Industry value chain analysis Fig. 18 Women's Health driver impact Fig. 19 Women's Health restraint impact Fig. 20 Women's Health strategic initiatives analysis Fig. 21 Women's Health: Application movement analysis Fig. 22 Women's Health: Application outlook and key takeaways Fig. 23 Hormonal Infertility market estimates and forecast, 2021 - 2033 Fig. 24 Contraceptives market estimates and forecast, 2021 - 2033 Fig. 25 Postmenopausal Osteoporosis market estimates and forecast, 2021 - 2033 Fig. 26 Endometriosis & Uterine Fibroids market estimates and forecast, 2021 - 2033 Fig. 27 Menopause market estimates and forecast, 2021 - 2033 Fig. 28 Polycystic Ovary Syndrome (PCOS) market estimates and forecast, 2021 - 2033 Fig. 29 Women's Health: Drug Class movement analysis Fig. 30 Women's Health: Drug Class outlook and key takeaways Fig. 31 Hormonal Therapies market estimates and forecast, 2021 - 2033 Fig. 32 Bone Health Agents market estimates and forecast, 2021 - 2033 Fig. 33 Fertility Agents market estimates and forecast, 2021 - 2033 Fig. 34 GnRH Modulators market estimates and forecast, 2021 - 2033 Fig. 35 Pain and Symptom Management market estimates and forecast, 2021 - 2033 Fig. 36 Metabolic Agents market estimates and forecast, 2021 - 2033 Fig. 37 Others market estimates and forecast, 2021 - 2033 Fig. 38 Women's Health: Age movement analysis Fig. 39 Women's Health: Age outlook and key takeaways Fig. 40 50 years and above market estimates and forecast, 2021 - 2033 Fig. 41 Postmenopausal Osteoporosis market estimates and forecast, 2021 - 2033 Fig. 42 Endometriosis & Uterine Fibroids market estimates and forecast, 2021 - 2033 Fig. 43 Menopause market estimates and forecast, 2021 - 2033 Fig. 44 Others market estimates and forecast, 2021 - 2033 Fig. 45 Others market estimates and forecast, 2021 - 2033 Fig. 46 Women's Health: Regional movement analysis Fig. 47 Women's Health: Regional outlook and key takeaways Fig. 48 Women's Health share and leading players Fig. 49 North America Women's Health market share and leading players Fig. 50 Europe Women's Health market share and leading players Fig. 51 Asia Pacific Women's Health market share and leading players Fig. 52 Latin America Women's Health market share and leading players Fig. 53 Middle East & Africa Women's Health market share and leading players Fig. 54 North America Women's Health Market SWOT Analysis Fig. 55 Europe Women's Health Market SWOT Analysis Fig. 56 Asia Pacific Women's Health Market SWOT Analysis Fig. 57 Latin America Women's Health Market SWOT Analysis Fig. 58 Middle East & Africa Women's Health Market SWOT Analysis Fig. 59 North America Women's Health Market Analysis, by country Fig. 60 North America Fig. 61 North America Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 62 U.S. Fig. 63 U.S. Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 64 Canada Fig. 65 Canada Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 66 Mexico Fig. 67 Mexico Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 68 Europe Fig. 69 Europe Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 70 UK Fig. 71 UK Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 72 Germany Fig. 73 Germany Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 74 France Fig. 75 France Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 76 Italy Fig. 77 Italy Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 78 Spain Fig. 79 Spain Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 80 Denmark Fig. 81 Denmark Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 82 Sweden Fig. 83 Sweden Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 84 Norway Fig. 85 Norway Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 86 Asia Pacific Fig. 87 Asia Pacific Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 88 China Fig. 89 China Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 90 Japan Fig. 91 Japan Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 92 India Fig. 93 India Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 94 Thailand Fig. 95 Thailand Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 96 South Korea Fig. 97 South Korea Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 98 Australia Fig. 99 Australia Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 100 Latin America Fig. 101 Latin America Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 102 Brazil Fig. 103 Brazil Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 104 Argentina Fig. 105 Argentina Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 106 Middle East & Africa Fig. 107 Middle East & Africa Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 108 South Africa Fig. 109 South Africa Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 110 Saudi Arabia Fig. 111 Saudi Arabia Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 112 UAE Fig. 113 UAE Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 114 Kuwait Fig. 115 Kuwait Women's Health Market Estimates and Forecasts 2021 - 2033 Fig. 116 Market share of key market players - Women's Health Market
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Grand View Research社の 医薬品分野 での最新刊レポート
本レポートと同じKEY WORD（womens health）の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
